About DESIGN-ZYME LLC
Design-Zyme LLC is a vertically-integrated biotech founded in 2015, specializing in the development of cutting-edge vaccines for unmet health needs, including opioid use disorder, Lyme disease, and fescue toxicosis. The company has secured $9M in non-dilutive funding from organizations such as DARPA and NIAID.
Development of multivalent hapten vaccines for small molecule targetsCreation of multivalent protein immunogen vaccines for pathogenic threatsData-driven research ensuring FDA standards for safety and efficacyNatural carbohydrate-based adjuvant solutions for safe and effective vaccine delivery via multiple routesModular vaccine technology capable of eliciting a range of antibodies for multivalent threats
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| DEVELOPMENT OF COVALENTLY BOUND HYALURONIC ACID AS AN ADJUVANT FOR MULTIVALENT LYME DISEASE VACCINE | Department of Health and Human Services | $3.0M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DESIGN-ZYME LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.